Principal Investigator: Les Lukavetsky.
Trial type(s): Medical devices, Medicines, Vaccines, Non-interventional studies, Tissues or Cell transplants.
Trial phase(s): Phase II, Phase III, Phase IV.
Medical area(s): Genetic Diseases, Hematology, Immunology, Infectious Diseases, Neurology, Oncohematology, Oncology, Rare Diseases, Rheumatology.
Disease(s): BPH, Cancer, Fungal Disease, Lymphoma, Multiple Sclerosis, Multiple myeloma, Neutropenia, acute lymphoid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, essential thrombocytopenia., myelodysplastic syndrome, myelofibrosis, polycythemia Vera.
Trial experience (full years): 22.
Clinical base (Hospital or Institution with beds): Lviv First territorial medical union..
Department(s) of Clinical base: Department of hematology and bone marrow transplantation.
opened 2023) at St. Panteleimon’s Hospital, Lviv — the only allogeneic BMT program in Western Ukraine, inside a network with 22 years of trial experience and Ukraine’s first CT coordination center. 700+ patients across 24 entities, 67 transplants since 2024. Largely treatment-naive catchment, EU-adjacent ICH-GCP regulation, 70 km from the Schengen border. PI: 22 years on multicenter trials. English-speaking, GCP-trained team.
Address info
Contact person: Ivan Salii.
Address of Clinical base: Ukraine, Lvivska Oblast, Lviv, Mykolaichuka, 9.
Tel.: +380677461585, +380671484784.
E-mail: sallivanmd@gmail.com.